A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiology
- PMID: 36479425
- PMCID: PMC9720437
- DOI: 10.1016/j.ebr.2022.100576
A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiology
Abstract
Autoimmune encephalitis (AE) is a condition of severe brain inflammation with a complex differential diagnosis. The identification of a specific neuronal antibody (NA) is not mandatory to diagnose AE. Moreover, even when a NA is detected, the clinical picture can be inconsequential (i.e., GAD-65) and not disease-specific (i.e., LGI1). Peculiar clinical manifestations and specific alterations of conventional tests as cerebral spinal fluid (CSF) and magnetic resonance imaging (MRI) can be sufficient to confirm the diagnostic suspicion of AE. New-onset seizures may be the first manifestation of AE and require immediate treatment. We report the case of a 19-year-old woman with sudden onset of focal motor seizures with unimpaired awareness, resistant to different intravenous antiseizure medications (ASMs). Ancillary tests (MRI, CSF analysis and electroencephalogram) were pathological and compatible with an autoimmune disorder of the brain. A weak positivity of GluR-3 antibody was detected in low serum dilution along with very high levels of angiotensin-converting enzyme in serum. After administration of high-dose corticosteroids, electro-clinical and neuroradiological pictures progressively normalized. This case report suggests that, even without a definite NA positivity, an inflammatory brain disorder of suspected autoimmune etiology should be considered based on clinical assessment and suggestive ancillary tests.
Keywords: Angiotensin-converting enzyme; Autoimmune brain disorders; Autoimmune encephalitis; Encephalitis.
© 2022 The Author(s).
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: GB has received speaker’s or consultancy fees from Eisai, Angelini Pharma and UCB Pharma. MT has served on scientific Advisory Boards for Biogen, Novartis, Roche, Merck, and Genzyme; has received speaker honoraria from Biogen Idec, Merck, Roche, Teva, Sanofi-Genzyme, and Novartis; and has received research grants for her Institution from Biogen Idec, Merck, Roche, and Novartis. ALN has received speaker’s or consultancy fees from Eisai, Mylan, Sanofi, Bial, GW, Arvelle Therapeutics, Angelini Pharma and UCB Pharma. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022. Qatar Med J. 2022. PMID: 35864917 Free PMC article.
-
Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.Front Neurol. 2020 May 5;11:280. doi: 10.3389/fneur.2020.00280. eCollection 2020. Front Neurol. 2020. PMID: 32431657 Free PMC article.
-
EEG Contribution to the Diagnosis of Antibody-Negative Autoimmune Encephalitis: A Case Report.Case Rep Neurol. 2021 Nov 18;13(3):739-743. doi: 10.1159/000519991. eCollection 2021 Sep-Dec. Case Rep Neurol. 2021. PMID: 35082642 Free PMC article.
-
Diagnostic tools for immune causes of encephalitis.Clin Microbiol Infect. 2019 Apr;25(4):431-436. doi: 10.1016/j.cmi.2018.12.012. Epub 2018 Dec 22. Clin Microbiol Infect. 2019. PMID: 30583056 Review.
-
Seizures in autoimmune encephalitis: specific features based on a systematic comparative study.Epileptic Disord. 2021 Dec 1;23(6):879-892. doi: 10.1684/epd.2021.1355. Epileptic Disord. 2021. PMID: 34704941
References
-
- López-Chiriboga AS, Clardy SL. Emerging subspecialties in neurology: autoimmune neurology. Neurology. 2017;89(11):e129-e133. 10.1212/WNL.0000000000004356. Epub 2017 Sep 11. PMID: 28894037. - PubMed
-
- Abboud H., Probasco J.C., Irani S., Ances B., Benavides D.R., Bradshaw M., et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757–768. doi: 10.1136/jnnp-2020-325300. Epub 2021 Mar 1. PMID: 33649022; PMCID: PMC8223680. - DOI - PMC - PubMed
-
- Titulaer M.J., McCracken L., Gabilondo I., Armangué T., Glaser C., Iizuka T., et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157–165. doi: 10.1016/S1474-4422(12)70310-1. Epub 2013 Jan 3. PMID: 23290630; PMCID: PMC3563251. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources